The government has confirmed the country’s first case of a Japanese national infected with the omicron variant of the coronavirus, marking the third case in the country, government sources said Monday.

The man in his 30s, who had traveled to Italy, was found to be infected with the heavily mutated variant after entering Japan via Tokyo’s Haneda Airport on Wednesday, according to the health ministry.

He is fully vaccinated after receiving two doses of Moderna Inc.’s COVID-19 vaccine in July and August, the sources said.

Prime Minister Fumio Kishida pledged Monday to “concentrate our limited medical resources on the omicron strain and take swift measures to protect the lives of the people.”

According to the Ministry of Health, Labor and Welfare, all of the other 41 passengers on the same flight as the man are being treated as close contacts. One has tested positive for the coronavirus but not the omicron variant.

Japan confirmed its first domestic case of the omicron variant on Nov. 30 — a Namibian diplomat in his 30s. It confirmed a second unrelated case, a man in his 20s who traveled from Peru, the following day.

Both men tested positive on arrival at Narita Airport in Chiba Prefecture.

In the two earlier cases, all passengers on the same flights were considered close contacts. In a shift in policy, all of those close contacts are being monitored and have been required to remain quarantined for a total of 14 days. They must also undergo PCR tests once every two days.

The health ministry has raised the level of caution against possible community infections with the omicron variant, tightening border controls and launching screening tests for the new strain.

The omicron variant has already been detected in dozens of countries, including the United States, Australia and parts of Europe since being first reported by South Africa last month.

Scientists are working to discover whether the highly mutated strain is more transmissible than the existing delta variant or able to evade immunity from vaccines or previous infections.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.